IE 11 is not supported. For an optimal experience visit our site on another browser.

Infinity Pharmaceuticals to Present at Piper Jaffray Healthcare Conference

CAMBRIDGE, Mass., Nov. 22, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Piper Jaffray 22nd Annual "Unplugged" Health Care Conference on Wednesday, December 1, 2010 at 8:30 a.m. EST in New York City.
/ Source: GlobeNewswire

CAMBRIDGE, Mass., Nov. 22, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Piper Jaffray 22nd Annual "Unplugged" Health Care Conference on Wednesday, December 1, 2010 at 8:30 a.m. EST in New York City.

A live webcast of Infinity's presentation will be accessible on the "investors/media" section of the company's website, , and will be available for 30 days following the event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.

CONTACT: Infinity Pharmaceuticals, Inc. Jaren Irene Madden 617-453-1336 Jaren.Madden@infi.com http://www.infi.com